Open AccessP23: Elvitegravir/cobicistat/emtricitabine/tenofovir DF demonstrates durable efficacy and safety versus efavirenz/emtricitabine/tenofovir DF at Week 144
Author(s) -
Hawkins Trevor,
Campo Rafael,
David Wormser,
Cohen Cal,
Joel E. Gallant,
Anthony Mills,
Paul Sax,
Zolopa Andrew,
Liu Hui C,
White Kirsten L,
Rhee Martin S,
Javier Szwarcberg
Publication year - 2014
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.7448/ias.17.2.19132
Subject(s) - elvitegravir , efavirenz , medicine , emtricitabine , cobicistat , tenofovir , human immunodeficiency virus (hiv) , pharmacology , virology , antiretroviral therapy , viral load